Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Other Non-Current Liabilities (2022 - 2024)

HeartSciences' Other Non-Current Liabilities history spans 3 years, with the latest figure at $32103.0 for Q4 2024.

  • For Q4 2024, Other Non-Current Liabilities changed N/A year-over-year to $32103.0; the TTM value through Oct 2024 reached $32103.0, changed N/A, while the annual FY2023 figure was $187450.0, 19.5% down from the prior year.
  • Other Non-Current Liabilities reached $32103.0 in Q4 2024 per HSCS's latest filing, down from $207592.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $232868.0 in Q2 2022 to a low of $32103.0 in Q4 2024.
  • Average Other Non-Current Liabilities over 3 years is $166926.3, with a median of $195514.0 recorded in 2023.
  • The largest YoY upside for Other Non-Current Liabilities was 50.46% in 2023 against a maximum downside of 19.5% in 2023.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $137967.0 in 2022, then surged by 50.46% to $207592.0 in 2023, then tumbled by 84.54% to $32103.0 in 2024.
  • Per Business Quant, the three most recent readings for HSCS's Other Non-Current Liabilities are $32103.0 (Q4 2024), $207592.0 (Q3 2023), and $187450.0 (Q2 2023).